Bristol-Myers and Eli Lilly Among Federated Investors’ Top Healthcare Stock Investments

Wall St. Watchdog reveals information regarding Federated Investors, Inc.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 137 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $2.881 billion.

  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Federated Investors, Inc. reported holding 8,459,517 shares with a market value of $244,987,605. This comprised 1.27% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 9,834,900 shares with a market value of $308,619,154. This comprised 1.83% of the total portfolio. The net change in shares for this position over the two quarters is 1,375,383. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Eli Lilly & Co. (NYSE:LLY): On 06/30/2011, Federated Investors, Inc. reported holding 5,895,457 shares with a market value of $221,256,494. This comprised 1.15% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 7,153,666 shares with a market value of $264,471,041. This comprised 1.57% of the total portfolio. The net change in shares for this position over the two quarters is 1,258,209. About Company: Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company’s products are sold in countries around the world. Eli Lilly’s products include neuroscience products, endocrine products, anti-infectives, cardiovascular agents, oncology products, and animal health products.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Federated Investors, Inc. reported holding 2,747,630 shares with a market value of $182,772,338. This comprised 0.95% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 3,654,195 shares with a market value of $232,735,675. This comprised 1.38% of the total portfolio. The net change in shares for this position over the two quarters is 906,565. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Federated Investors, Inc. reported holding 3,158,469 shares with a market value of $166,198,635. This comprised 0.86% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 4,092,262 shares with a market value of $209,278,276. This comprised 1.24% of the total portfolio. The net change in shares for this position over the two quarters is 933,793. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
  • Cubist Pharmaceuticals Inc. (NASDAQ:CBST): On 06/30/2011, Federated Investors, Inc. reported holding 5,725,000 shares with a market value of $206,042,760. This comprised 1.07% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 5,634,300 shares with a market value of $199,003,474. This comprised 1.18% of the total portfolio. The net change in shares for this position over the two quarters is -90,700. About Company: Cubist Pharmaceuticals, Inc. is a drug company that discovers, develops, and commercializes novel drugs to treat infections. The Company’s lead product is a unique agent with bactericidal activity that addresses the critical need for new antibiotics with potent activity against life threatening infections.
  • Glaxosmithkline Plc (NYSE:GSK): On 06/30/2011, Federated Investors, Inc. reported holding 2,542,076 shares with a market value of $109,055,064. This comprised 0.56% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 2,768,921 shares with a market value of $114,328,751. This comprised 0.68% of the total portfolio. The net change in shares for this position over the two quarters is 226,845. About Company: GlaxoSmithKline plc is a research-based pharmaceutical group that develops, manufactures and markets vaccines, prescription and over-the-counter medicines, as well as health-related consumer products. The Group, which also provides laboratory testing and disease management services, specializes in treatments for respiratory, central nervous system, gastro-intestinal and genetic disorders
  • Alkermes Inc. (NASDAQ:ALKS): On 06/30/2011, Federated Investors, Inc. reported holding 6,863,750 shares with a market value of $127,665,753. This comprised 0.66% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 6,575,128 shares with a market value of $100,270,702. This comprised 0.59% of the total portfolio. The net change in shares for this position over the two quarters is -288,622. About Company: Alkermes, Inc. develops products based on drug delivery technologies. The Company is focusing on controlled, sustained release of injectable drugs, as well as the delivery of drugs into the brain past the blood-brain barrier. Alkermes is also focusing on the oral delivery of drugs, and the development of pharmaceutical products based on pulmonary drug delivery technologies.
  • Seattle Genetics Inc. (NASDAQ:SGEN): On 06/30/2011, Federated Investors, Inc. reported holding 4,384,903 shares with a market value of $89,978,212. This comprised 0.47% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 4,382,800 shares with a market value of $83,448,516. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is -2,103. About Company: Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company’s technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Federated Investors, Inc. reported holding 5,861,817 shares with a market value of $120,753,432. This comprised 0.63% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 4,566,286 shares with a market value of $80,731,938. This comprised 0.48% of the total portfolio. The net change in shares for this position over the two quarters is -1,295,531. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Watson Pharmaceuticals Inc. (NYSE:WPI): On 06/30/2011, Federated Investors, Inc. reported holding 1,069,980 shares with a market value of $73,539,729. This comprised 0.38% of the total portfolio. On 09/30/2011, Federated Investors, Inc. reported holding 1,130,211 shares with a market value of $77,136,901. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is 60,231. About Company: Watson Pharmaceuticals, Inc. develops, manufactures, and sells generic and brand name pharmaceutical products. The Company’s core focus is specialty products, nephrology, urology, and generic products.

(Note: Data regarding Federated Investors, Inc.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>